tm logo

Monitor this mark

View On USPTO

RIVOCEL
Dead/Abandoned
ABANDONED - NO STATEMENT OF USE FILED

no statement of use filed

on 21 Mar 2022

Last Applicant/ Owned by

Bellicum Pharmaceuticals, Inc.

2130 W. Holcombe Drive, Suite 800

Houston

TX

77030

Serial Number

88238667 filed on 21st Dec 2018

Registration Number

N/A

Correspondent Address

John Paul Oleksiuk

JOHN PAUL OLEKSIUK

1299 PENNSYLVANIA AVENUE, NW, SUITE 700

WASHINGTON, DC 20004-2400

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

RIVOCEL

Pharmaceutical preparations, namely, preparations for use in the treatment of cancer and tumors; pharmaceutical preparations for immunotherapy, including T Cell therapy

Classification Information

Class [005]
Pharmaceutical Products

Pharmaceutical preparations, namely, preparations for use in the treatment of cancer and tumors; pharmaceutical preparations for immunotherapy, including T Cell therapy

Mark Details

Serial Number

No 88238667

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 306803-20000

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History

Show more

Status DateAction Taken
21st Mar 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
21st Mar 2022ABANDONMENT - NO USE STATEMENT FILED
17th Aug 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
22nd Jun 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
22nd Jun 2021PUBLISHED FOR OPPOSITION
02th Jun 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
14th May 2021APPROVED FOR PUB - PRINCIPAL REGISTER
29th Oct 2020REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
15th Apr 2020REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
25th Sep 2019REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED